The Naloxone drug is predominantly used across emergency rooms in the U.S. to treat life-threatening opioid overdoses. FDA’s change clears the way for pharmaceutical companies to sell Naloxone without a prescription. The U.S. Food & Drug Administration (FDA), has reportedly announced that it would be …
The venture fund also announced its investment in Innovaccer, a healthcare SaaS startup. The fund aims to provide a helping hand to entrepreneurs and boost innovation and growth across the region. Microsoft Corporation (Microsoft), a renowned American multinational technology giant, has reportedly announced that the …
Roche, in its recent announcement has unveiled its innovative uPath enterprise software for digital pathology. Reportedly, the new software is likely to offer a new standard of personalization of workflows in pathology, besides improving on VENTANA Virtuoso – the previous version. According to sources familiar …
The acquisition will offer customers with well-reputed and advanced eye care operations and ambulatory surgery centers in the Upstate area. Renowned eye care practice management firm, Eye Health America (EHA) has recently announced its acquisition of Donelson Eye Associates in Greenville, South Carolina. Reportedly, the …
The study shows improvement in PFS in patients treated with metastatic gastric cancer therapy varlitinib. Renowned clinical-stage biopharmaceutical firm, ASLAN Pharmaceuticals has recently announced an update on the global placebo-controlled phase 2 clinical study of varlitinib, as first-line therapy in metastatic gastric cancer patients, while …
The American company will be paying millions to CytoReason for its unparalleled models. CytoReason, the Israel based machine learning company, that is credited for developing immune system cell-centered models that necessarily aid in drug discovery, recently entered a collaboration with American pharmaceutical corporation, Pfizer Inc. …
SIRION Biotech GmbH, a global leader in viral vector-based gene delivery technologies, has reportedly inked a collaboration contract and license with Denali Therapeutics, a biopharma firm which has developed a wide range of product candidates for treating neurodegenerative diseases. According to FierceBiotech, the two firms …
The Canadian cannabis firm Aphria Inc. has reportedly revealed to have concluded the acquisition of a major Germany-based importer and distributor of pharmaceutical products, CC Pharma GmbH. As per trusted sources, Aphria Inc. has paid €18.92 million in cash to the former stakeholders of CC …
Pharmaceutical major Lupin has made it to the headlines upon attaining the approval from the U.S. Food and Drug Administration for selling its Lurasidone Hydrochloride tablets, used to treat schizophrenia, in the American market. The approved product is a generic form of Sunovion Pharmaceuticals’ Latuda …
